SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAA
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The goal of this interventional clinical trial is to evaluate the dose of radiation of
Technetium-99m macroaggregated-albumin (99mTc-MAA) after an intra-arterial injection to the
whole body and non-liver critical organs in patients who are undergoing evaluation for
SIR-Spheres treatment for hepatocellular carcinoma.